세계의 투렛 증후군 시장 보고서(2025년)

Tourette syndrome (TS) is a neurological disorder characterized by involuntary, repetitive movements and vocalizations known as tics. Typically beginning in childhood, TS can vary in severity and is influenced by both genetic and environmental factors. Symptoms often worsen during times of stress or excitement. Treatment options, including behavioral therapy and medication, can help manage and reduce the frequency of tics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main types of tics in Tourette syndrome are motor tics and vocal tics. Motor tics involve sudden, involuntary body movements, such as blinking, head jerking, or shoulder shrugging. TS can be diagnosed through blood tests, imaging, and other diagnostic methods. Treatment options include medications, behavioral therapy, neuromodulation therapies, complementary and alternative medicine, among others. The severity of TS can be mild, moderate, or severe, and it is addressed by individuals with Tourette syndrome, healthcare professionals, educational institutions, non-profit organizations, and research institutions.

The tourette syndrome market research report is one of a series of new reports from The Business Research Company that provides tourette syndrome market statistics, including tourette syndrome industry global market size, regional shares, competitors with a tourette syndrome market share, detailed tourette syndrome market segments, market trends and opportunities, and any further data you may need to thrive in the tourette syndrome industry. This tourette syndrome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tourette syndrome market size has grown rapidly in recent years. It will grow from $1.95 billion in 2024 to $2.16 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. The growth observed during the historical period can be linked to a greater awareness of neurological disorders, a rise in the prevalence of tic disorders, expanding research on genetic factors, increased funding for rare disease research, and a growing demand for personalized medicine.

The tourette syndrome market size is expected to see rapid growth in the next few years. It will grow to $3.20 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth projected during the forecast period can be attributed to expanding public health initiatives for neurological disorders, a rising prevalence of co-occurring psychiatric conditions, an increase in clinical trials for new treatment options, a growing demand for alternative and complementary therapies, and a rise in the use of natural and herbal remedies. Key trends during this period include the development of gene-based therapies, advancements in deep brain stimulation technology, the creation of machine learning models for symptom prediction, the introduction of wearable neurofeedback devices, and the integration of virtual reality into behavioral therapy.

Government initiatives aimed at addressing neurological disorders are expected to significantly contribute to the growth of the Tourette syndrome market. These initiatives involve programs, policies, or actions carried out by authorities to meet public needs, promote progress, or improve societal well-being. Such government efforts drive advancements in Tourette syndrome treatment by increasing funding for research and therapeutic programs, leading to better diagnostic tools, enhanced treatment options, and increased public awareness, ultimately improving patient care and support. For example, in February 2025, the Department of Health and Social Care, a UK-based ministerial department, reported that the Medical Research Council (MRC) established two Centres of Research Excellence (CoRE) in December 2024, each dedicated to gene therapy research with investments of up to $65 million (£50 million) over 14 years. One of these centers, focused on therapeutic genomics, aims to make significant strides in treating rare genetic disorders by developing scalable processes for adapting successful genetic therapies to new conditions, thus facilitating the creation of personalized treatments. As a result, these growing government initiatives are driving the advancement of the Tourette syndrome market.

Leading companies in the Tourette syndrome market are prioritizing the development of technologically advanced products, such as wearable devices, to improve symptom monitoring, patient management, and treatment outcomes. Wearable devices are smart electronic gadgets worn on the body that track and analyze health or activity data in real time. For example, in May 2022, Neurotherapeutics Ltd., a UK-based health tech company, initiated a clinical trial for a wearable device designed to manage Tourette syndrome. This device works by delivering targeted electrical stimulation to the median nerve at the wrist, modulating brain oscillations related to tic suppression, thus reducing their frequency and intensity. Non-invasive and user-friendly, the device can be easily integrated into daily life, providing individuals with a convenient and discreet treatment option that can be used at home, thanks to its wristwatch-like design.

In February 2025, Relmada Therapeutics Inc., a US-based biotechnology firm, acquired Sepranolone, a Phase 2b-ready neurosteroid, from Asarina Pharma AB for an undisclosed amount. This acquisition aligns with Relmada's goal of addressing unmet needs in treating central nervous system (CNS) disorders. Sepranolone has shown promising results in Phase 2a trials, demonstrating significant reductions in tics and improvements in quality of life, along with strong safety data. Asarina Pharma AB, based in Sweden, is a provider of treatments for Tourette syndrome.

Major players in the tourette syndrome market are AstraZeneca PLC, F Hoffmann-La Roche AG, AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb, Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd, Otsuka Holdings Co Ltd, Biogen Inc, Mitsubishi Tanabe Pharma Corporation, Eisai Co. Ltd., Jazz Pharmaceuticals plc, Kyowa Kirin Co. Ltd., Amneal Pharmaceuticals, Mallinckrodt Pharmaceuticals, Neurocrine Biosciences Inc.

North America was the largest region in the tourette syndrome market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in tourette syndrome report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tourette syndrome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tourette syndrome market consists of sales of sensory stimulation devices, neurofeedback devices, speech and communication aids, mental health support apps. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tourette Syndrome Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tourette syndrome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tourette syndrome ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tourette syndrome market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Types: Motor Tics; Vocal Tics
• 2) By Diagnosis: Blood Diagnosis; Imaging Diagnosis; Other Diagnosis
• 3) By Type Of Treatment: Medications; Behavioral Therapy; Neuromodulation Therapies; Complementary And Alternative Medicine; Other Therapies
• 4) By Severity Of Syndrome: Mild; Moderate; Severe
• 5) By End Users: Individuals With Tourette Syndrome; Healthcare Professionals; Educational Institutions; Non-Profit Organizations; Research Institutions
• Subsegments:
• 1) By Motor Tics: Simple Motor Tics; Complex Motor Tics
• 2) By Vocal Tics: Simple Vocal Tics; Complex Vocal Tics
• Companies Mentioned: AstraZeneca PLC; F Hoffmann-La Roche AG; AbbVie Inc.; Bayer AG; Sanofi S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tourette Syndrome Market Characteristics

3. Tourette Syndrome Market Trends And Strategies

4. Tourette Syndrome Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Tourette Syndrome Growth Analysis And Strategic Analysis Framework

• 5.1. Global Tourette Syndrome PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Tourette Syndrome Market Growth Rate Analysis
• 5.4. Global Tourette Syndrome Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Tourette Syndrome Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Tourette Syndrome Total Addressable Market (TAM)

6. Tourette Syndrome Market Segmentation

• 6.1. Global Tourette Syndrome Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Motor Tics
• Vocal Tics
• 6.2. Global Tourette Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Diagnosis
• Imaging Diagnosis
• Other Diagnosis
• 6.3. Global Tourette Syndrome Market, Segmentation By Type Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medications
• Behavioral Therapy
• Neuromodulation Therapies
• Complementary And Alternative Medicine
• Other Therapies
• 6.4. Global Tourette Syndrome Market, Segmentation By Severity Of Syndrome, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mild
• Moderate
• Severe
• 6.5. Global Tourette Syndrome Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Individuals With Tourette Syndrome
• Healthcare Professionals
• Educational Institutions
• Non-Profit Organizations
• Research Institutions
• 6.6. Global Tourette Syndrome Market, Sub-Segmentation Of Motor Tics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Simple Motor Tics
• Complex Motor Tics
• 6.7. Global Tourette Syndrome Market, Sub-Segmentation Of Vocal Tics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Simple Vocal Tics
• Complex Vocal Tics

7. Tourette Syndrome Market Regional And Country Analysis

• 7.1. Global Tourette Syndrome Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Tourette Syndrome Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tourette Syndrome Market

• 8.1. Asia-Pacific Tourette Syndrome Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Tourette Syndrome Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Tourette Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Tourette Syndrome Market, Segmentation By Type Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tourette Syndrome Market

• 9.1. China Tourette Syndrome Market Overview
• 9.2. China Tourette Syndrome Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Tourette Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Tourette Syndrome Market, Segmentation By Type Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tourette Syndrome Market

• 10.1. India Tourette Syndrome Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Tourette Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Tourette Syndrome Market, Segmentation By Type Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tourette Syndrome Market

• 11.1. Japan Tourette Syndrome Market Overview
• 11.2. Japan Tourette Syndrome Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Tourette Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Tourette Syndrome Market, Segmentation By Type Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tourette Syndrome Market

• 12.1. Australia Tourette Syndrome Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Tourette Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Tourette Syndrome Market, Segmentation By Type Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tourette Syndrome Market

• 13.1. Indonesia Tourette Syndrome Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Tourette Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Tourette Syndrome Market, Segmentation By Type Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tourette Syndrome Market

• 14.1. South Korea Tourette Syndrome Market Overview
• 14.2. South Korea Tourette Syndrome Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Tourette Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Tourette Syndrome Market, Segmentation By Type Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tourette Syndrome Market

• 15.1. Western Europe Tourette Syndrome Market Overview
• 15.2. Western Europe Tourette Syndrome Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Tourette Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Tourette Syndrome Market, Segmentation By Type Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tourette Syndrome Market

• 16.1. UK Tourette Syndrome Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Tourette Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Tourette Syndrome Market, Segmentation By Type Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tourette Syndrome Market

• 17.1. Germany Tourette Syndrome Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Tourette Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Tourette Syndrome Market, Segmentation By Type Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tourette Syndrome Market

• 18.1. France Tourette Syndrome Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Tourette Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Tourette Syndrome Market, Segmentation By Type Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tourette Syndrome Market

• 19.1. Italy Tourette Syndrome Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Tourette Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Tourette Syndrome Market, Segmentation By Type Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tourette Syndrome Market

• 20.1. Spain Tourette Syndrome Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Tourette Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Tourette Syndrome Market, Segmentation By Type Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tourette Syndrome Market

• 21.1. Eastern Europe Tourette Syndrome Market Overview
• 21.2. Eastern Europe Tourette Syndrome Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Tourette Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Tourette Syndrome Market, Segmentation By Type Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tourette Syndrome Market

• 22.1. Russia Tourette Syndrome Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Tourette Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Tourette Syndrome Market, Segmentation By Type Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tourette Syndrome Market

• 23.1. North America Tourette Syndrome Market Overview
• 23.2. North America Tourette Syndrome Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Tourette Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Tourette Syndrome Market, Segmentation By Type Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tourette Syndrome Market

• 24.1. USA Tourette Syndrome Market Overview
• 24.2. USA Tourette Syndrome Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Tourette Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Tourette Syndrome Market, Segmentation By Type Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tourette Syndrome Market

• 25.1. Canada Tourette Syndrome Market Overview
• 25.2. Canada Tourette Syndrome Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Tourette Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Tourette Syndrome Market, Segmentation By Type Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tourette Syndrome Market

• 26.1. South America Tourette Syndrome Market Overview
• 26.2. South America Tourette Syndrome Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Tourette Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Tourette Syndrome Market, Segmentation By Type Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tourette Syndrome Market

• 27.1. Brazil Tourette Syndrome Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Tourette Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Tourette Syndrome Market, Segmentation By Type Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tourette Syndrome Market

• 28.1. Middle East Tourette Syndrome Market Overview
• 28.2. Middle East Tourette Syndrome Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Tourette Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Tourette Syndrome Market, Segmentation By Type Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tourette Syndrome Market

• 29.1. Africa Tourette Syndrome Market Overview
• 29.2. Africa Tourette Syndrome Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Tourette Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Tourette Syndrome Market, Segmentation By Type Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tourette Syndrome Market Competitive Landscape And Company Profiles

• 30.1. Tourette Syndrome Market Competitive Landscape
• 30.2. Tourette Syndrome Market Company Profiles
  • 30.2.1. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Tourette Syndrome Market Other Major And Innovative Companies

• 31.1. Bristol-Myers Squibb
• 31.2. Novartis AG
• 31.3. Takeda Pharmaceutical Company Limited
• 31.4. Eli Lilly and Company
• 31.5. Viatris Inc.
• 31.6. Teva Pharmaceutical Industries Ltd
• 31.7. Otsuka Holdings Co Ltd
• 31.8. Biogen Inc
• 31.9. Mitsubishi Tanabe Pharma Corporation
• 31.10. Eisai Co. Ltd.
• 31.11. Jazz Pharmaceuticals plc
• 31.12. Kyowa Kirin Co. Ltd.
• 31.13. Amneal Pharmaceuticals
• 31.14. Mallinckrodt Pharmaceuticals
• 31.15. Neurocrine Biosciences Inc

32. Global Tourette Syndrome Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tourette Syndrome Market

34. Recent Developments In The Tourette Syndrome Market

35. Tourette Syndrome Market High Potential Countries, Segments and Strategies

• 35.1 Tourette Syndrome Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Tourette Syndrome Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Tourette Syndrome Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r34997_Tourette_Syndrome_GMR_2025